TP53 genetic testing could have been considered according to the Chompret criteria [7,8] because both the index patient and one first-degree relative, i.e. her son, had cancers from the LFS tumor spectrum (breast, brain) before 46 years of age. Here, TP53 is linked to neoplasm.